Skip to content
healthcare.dev

Mirabgeorn

NDC 67184-0572, mirabegron, tablet, film coated, extended release, from Qilu Pharmaceutical Co., Ltd..

Product NDC
67184-0572
Status
Listed
Labeler
Qilu Pharmaceutical Co., Ltd.
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA217989
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0572 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • MIRABEGRON50 mg/1

Pharmacologic classes

Adrenergic beta3-Agonists [MoA]; Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]; beta3-Adrenergic Agonist [EPC]

Package NDCNDC-11Package
67184-0572-16718405720130 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (67184-0572-1)
67184-0572-26718405720290 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (67184-0572-2)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/98247602-29b9-4621-8eeb-519e40b883b9

Use it

Look up 67184-0572 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0572 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67184-0572. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.